Reports for SANIS HEALTH INC
Company Name
SANIS HEALTH INC
Totals |
||
Shortage reports |
636 |
|
| Actual shortage: | 62 (10%) | |
| Anticipated shortage: | 1 (0%) | |
| Avoided shortage: | 16 (3%) | |
| Resolved: | 557 (88%) | |
Discontinuation Reports |
72 |
|
| To be discontinued: | 7 (10%) | |
| Discontinued: | 54 (75%) | |
| Reversed: | 11 (15%) | |
Late reports |
52 (7%) |
|
Overdue reports |
20 (29%) |
|
Shortage reports
| Brand name | Strength | Dosage | Status | Date Created | Date Updated | Reports |
|---|---|---|---|---|---|---|
| GABAPENTIN | 100MG | CAPSULE | Resolved | 2017-12-15 | 2017-12-22 | 33110 |
| GABAPENTIN | 800MG | TABLET | Resolved | 2020-05-11 | 2020-10-21 | 114766 |
| GABAPENTIN | 600MG | TABLET | Resolved | 2020-05-11 | 2020-10-21 | 114770 |
| GABAPENTIN | 300MG | CAPSULE | Resolved | 2023-08-29 | 2023-10-23 | 203128 |
| GABAPENTIN | 100MG | CAPSULE | Resolved | 2023-10-23 | 2023-11-14 | 207859 |
| GABAPENTIN | 300MG | CAPSULE | Resolved | 2023-11-22 | 2024-03-08 | 211055 |
| GABAPENTIN | 100MG | CAPSULE | Resolved | 2024-01-30 | 2024-03-14 | 217766 |
| GABAPENTIN | 300MG | CAPSULE | Resolved | 2024-02-26 | 2024-06-19 | 220627 |
| GABAPENTIN | 400MG | CAPSULE | Resolved | 2024-03-25 | 2024-08-03 | 223259 |
| GABAPENTIN | 100MG | CAPSULE | Resolved | 2024-05-28 | 2024-10-08 | 228997 |
| GABAPENTIN | 800MG | TABLET | Actual shortage | 2024-07-03 | 2024-12-02 | 232020 |
| GABAPENTIN | 300MG | CAPSULE | Avoided shortage | 2024-08-19 | 2024-09-04 | 235471 |
| GABAPENTIN | 300MG | CAPSULE | Resolved | 2024-11-18 | 2024-12-19 | 243265 |
| GALANTAMINE ER | 8MG | CAPSULE (EXTENDED RELEASE) | Resolved | 2020-05-11 | 2021-02-10 | 114761 |
| GALANTAMINE ER | 8MG | CAPSULE (EXTENDED RELEASE) | Resolved | 2020-07-08 | 2021-02-10 | 119747 |
| GALANTAMINE ER | 8MG | CAPSULE (EXTENDED RELEASE) | Resolved | 2023-07-31 | 2024-01-30 | 200443 |
| GALANTAMINE ER | 16MG | CAPSULE (EXTENDED RELEASE) | Resolved | 2023-10-23 | 2024-04-04 | 207850 |
| GALANTAMINE ER | 8MG | CAPSULE (EXTENDED RELEASE) | Resolved | 2024-02-12 | 2024-04-04 | 219378 |
| GALANTAMINE ER | 8MG | CAPSULE (EXTENDED RELEASE) | Resolved | 2025-04-01 | 2025-06-14 | 253778 |
| GLICLAZIDE MR | 60MG | TABLET (EXTENDED-RELEASE) | Actual shortage | 2024-03-26 | 2025-09-29 | 223453 |
Discontinuation reports
| Brand name | Strength | Dosage | Status | Date Created | Date Updated | Reports |
|---|---|---|---|---|---|---|
| RAMIPRIL-HCTZ | 25.0MG 10.0MG | TABLET | Discontinued | 2017-03-16 | 2017-03-16 | 3026 |
| RAMIPRIL-HCTZ | 12.5MG 5.0MG | TABLET | Discontinued | 2017-03-16 | 2017-03-16 | 3029 |
| RAMIPRIL-HCTZ | 25.0MG 5.0MG | TABLET | Discontinued | 2017-03-16 | 2017-03-16 | 3032 |
| RISEDRONATE | 35MG | TABLET | Discontinued | 2024-02-28 | 2024-02-29 | 220861 |
| ROPINIROLE | 5MG | TABLET | Discontinued | 2017-03-31 | 2017-03-31 | 4945 |
| SOLIFENACIN | 5MG | TABLET | Discontinued | 2023-09-26 | 2023-09-26 | 205215 |
| SOLIFENACIN | 10MG | TABLET | Reversed | 2024-07-24 | 2025-01-13 | 233602 |
| TERAZOSIN | 10MG | TABLET | To be discontinued | 2021-12-16 | 2021-12-16 | 151275 |
| TERAZOSIN | 1MG | TABLET | To be discontinued | 2021-12-16 | 2021-12-16 | 151278 |
| TERAZOSIN | 2MG | TABLET | To be discontinued | 2021-12-16 | 2021-12-16 | 151281 |
| TERAZOSIN | 5MG | TABLET | To be discontinued | 2021-12-16 | 2021-12-16 | 151284 |
| TRAMADOL/ACET | 325MG 37.5MG | TABLET | Discontinued | 2020-04-08 | 2020-07-07 | 111524 |